Ryan David Morin

Ryan David Morin

Auto-generated profile, based on publicly available information

Ryan David Morin

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Cancer Cell
Verified
Journal Article
Closed access
GWGeorge W. Wright
George W. Wright
DHDa Wei Huang
Da Wei Huang
JPJames D. Phelan
James D. Phelan
ZCZana A. Coulibaly
Zana A. Coulibaly
SRSandrine Roulland
Sandrine Roulland
LSLouis M. Staudt
Louis M. Staudt

8 October 2009 in Nature
Verified
Journal Article
Open access
PDF file
SSSohrab P. Shah
Sohrab P. Shah
RMRyan D. Morin
Ryan D. Morin
JKJaswinder Khattra
Jaswinder Khattra
LPLeah Prentice
Leah Prentice
TPTrevor J Pugh
Trevor J Pugh
SASamuel Aparicio
Samuel Aparicio
Next-generation sequencing approaches have been used to investigate the genomes and transcriptomes of an oestrogen-receptor-α-positive metastatic lobular breast cancer from a patient — rather than from a cell line or xenograft — over a 9-year period between the diagnosis of the primary tumour and the appearance of metastasis. Comparison of the somatic non-synonymous coding mutations in the metastasis and the primary tumour of the same patient and the combined analysis of genome and transcriptome data provided insights into the mutational evolution that can occur with disease progression. The cover shows sequence elements of the HAUS3 locus, one of the genes found to be mutated in the tissue (shown in the background) from the primary lobular cancer used for this work. Advances in next generation sequencing have made it possible to precisely characterize the coding mutations that occur during the development and progression of individual cancers. Here, this technique is used to sequence the genomes and transcriptomes of an oestrogen-receptor-α-positive metastatic lobular breast cancer; significant evolution is found to occur with disease progression. Recent advances in next generation sequencing1,2,3,4 have made it possible to precisely characterize all somatic coding mutations that occur during the development and progression of individual cancers. Here we used these approaches to sequence the genomes (>43-fold coverage) and transcriptomes of an oestrogen-receptor-α-positive metastatic lobular breast cancer at depth. We found 32 somatic non-synonymous coding mutations present in the metastasis, and measured the frequency of these somatic mutations in DNA from the primary tumour of the same patient, which arose 9 years earlier. Five of the 32 mutations (in ABCB11, HAUS3, SLC24A4, SNX4 and PALB2) were prevalent in the DNA of the primary tumour removed at diagnosis 9 years earlier, six (in KIF1C, USP28, MYH8, MORC1, KIAA1468 and RNASEH2A) were present at lower frequencies (1–13%), 19 were not detected in the primary tumour, and two were undetermined. The combined analysis of genome and transcriptome data revealed two new RNA-editing events that recode the amino acid sequence of SRP9 and COG3. Taken together, our data show that single nucleotide mutational heterogeneity can be a property of low or intermediate grade primary breast cancers and that significant evolution can occur with disease progression.

25 June 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SSSohrab P. Shah
Sohrab P. Shah
MKMartin Köbel
Martin Köbel
JSJanine Senz
Janine Senz
RMRyan D. Morin
Ryan D. Morin
BCBlaise A. Clarke
Blaise A. Clarke
DHDavid G. Huntsman
David G. Huntsman
Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian sex cord–stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, their histopathological diagnosis can be challenging, and there is no curative treatment beyond surgery. We analyzed four adult-type GCTs using whole-transcriptome paired-end RNA sequencing. We identified putative GCT-specific mutations that were present in at least three of these samples but were absent from the transcriptomes of 11 epithelial ovarian tumors, published human genomes, and databases of single-nucleotide polymorphisms. We confirmed these variants by direct sequencing of complementary DNA and genomic DNA. We then analyzed additional tumors and matched normal genomic DNA, using a combination of direct sequencing, analyses of restriction-fragment–length polymorphisms, and TaqMan assays. All four index GCTs had a missense point mutation, 402C→G (C134W), in FOXL2, a gene encoding a transcription factor known to be critical for granulosa-cell development. The FOXL2 mutation was present in 86 of 89 additional adult-type GCTs (97%), in 3 of 14 thecomas (21%), and in 1 of 10 juvenile-type GCTs (10%). The mutation was absent in 49 SCSTs of other types and in 329 unrelated ovarian or breast tumors. Whole-transcriptome sequencing of four GCTs identified a single, recurrent somatic mutation (402C→G) in FOXL2 that was present in almost all morphologically identified adult-type GCTs. Mutant FOXL2 is a potential driver in the pathogenesis of adult-type GCTs.

8 November 2009 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
DSDaniel T Starczynowski
Daniel T Starczynowski
FKFlorian Kuchenbauer
Florian Kuchenbauer
BABob Argiropoulos
Bob Argiropoulos
SSSandy Sung
Sandy Sung
RMRyan Morin
Ryan Morin
AKAly Karsan
Aly Karsan

15 August 2013 in Blood
Verified
Journal Article
Open access
PDF file
RMRyan D. Morin
Ryan D. Morin
KMKaren Mungall
Karen Mungall
EPErin Pleasance
Erin Pleasance
AMAndrew J. Mungall
Andrew J. Mungall
RGRodrigo Goya
Rodrigo Goya
MMMarco Marra
Marco Marra
Key Points: Complete genome sequence analysis of 40 DLBCL tumors and 13 cell lines reveals novel somatic point mutations, rearrangements, and fusions. Recurrence of mutations in genes involved in B-cell homing were identified in germinal center B-cell DLBCLs.

1 July 2008 in BioTechniques
Verified
Journal Article
Open access
RMRyan D. Morin
Ryan D. Morin
MBMatthew Bainbridge
Matthew Bainbridge
AFAnthony Fejes
Anthony Fejes
MHMartin Hirst
Martin Hirst
MKMartin Krzywinski
Martin Krzywinski
MMMarco Marra
Marco Marra
Sequence-based methods for transcriptome characterization have typically relied on generation of either serial analysis of gene expression tags or expressed sequence tags. Although such approaches ... ‘Illumina’-ting the HeLa Transcriptome Characterization of transcriptomes with sequencing approaches such as EST (expressed sequence tag) or SAGE (serial analysis of gene expression) are tag-based,...